Overview
- Adults receiving six or more gabapentin prescriptions were 29% more likely to develop dementia and 85% more likely to develop mild cognitive impairment within 10 years.
- Risks rose with prescription frequency: those with 12 or more prescriptions faced a 40% greater dementia likelihood and a 65% higher mild cognitive impairment risk compared to users with three to eleven fills.
- Middle-aged adults (35–64) exhibited especially elevated risks—more than doubling dementia odds and tripling mild cognitive impairment risks—while 18- to 34-year-olds showed no increased incidence.
- Researchers drew on TriNetX’s federated electronic health records from 68 U.S. health systems in a retrospective cohort study that cannot establish causation or account for dosage and duration.
- The findings prompt recommendations for regular cognitive screening of gabapentin users and further research to determine whether the drug itself contributes to cognitive decline amidst potential confounding factors.